Alexandra Ntorkou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Alexandra Ntorkou has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Athina C. Tsili
Department of Clinical Radiology, Faculty of Medicine, School of Health Sciences, University of Ioannina, University Campus, 45110 Ioannina, Greece
5 shared publications - Loukas G. Astrakas
University of Ioannina, Ioannina, Greece
5 shared publications - Maria I. Argyropoulou
University of Ioannina
5 shared publications - Nikolaos Sofikitis
Department of Urology, School of Medicine, Ioannina University, Ioannina, Greece
5 shared publications - Monique Elmaleh-Bergès
Radiology Department AP‐HP, Robert‐Debré University Hospital Paris France
4 shared publications - Vasilios Maliakas
Department of Clinical Radiology, School of Health Sciences, Faculty of Medicine, University of Ioannina, University Campus, 45110, Ioannina, Greece
4 shared publications
Latest Publications
- Open Access
- 19 May 2025
- Published by Wiley in Human Brain Mapping
- Vol. 46 (8) , e70233
Pattern of Deep Grey Matter Undersizing Boosts MRI‐Based Diagnostic Classifiers in Fetal Alcohol Spectrum Disorders
In fetal alcohol spectrum disorders (FASD), brain growth deficiency is a hallmark of subjects with both fetal alcohol syndrome (FAS) and nonsyndromic FASD (NS‐FASD, that is, those without specific diagnostic features). Although previous studies have suggested that the deep grey matter is heterogeneously affected at the group level, it has not yet been established within proper scaling modeling, nor has it been given a place in the FASD diagnostic criteria where neuroanatomical features still contribute almost nothing to diagnostic specificity. We segmented a 1.5T T1‐weighted brain MRI dataset of 90 monocentric FASD patients (53 FAS, 37 NS‐FASD) and 95 typically developing controls (ages 6–20), using volBrain‐vol2Brain as reference, and both Freesurfer‐SAMSEG and FSL‐FIRST to estimate result robustness. The segmentation resulted in seven anatomical volumes: total brain (TBV), total deep grey matter, caudate, putamen, globus pallidus, thalamus, and accumbens. After adjusting for confounds, we fitted the scaling relationship between deep grey matter nuclei volumes (Vi) and TBV (Vi = b × TBVa) and evaluated the effect of FAS on scaling. We then estimated the volumetric deviation from typical scaling (vDTS) for each deep grey nucleus volume in the FAS sample. Finally, we tested the improvement of FAS versus control classifiers based on total deep grey matter vDTS or total brain deviation from typical volume, by adding the five nuclear vDTS, both in terms of performance and generalizability to NS‐FASD. Scaling was significantly different between the FAS and control groups for all deep grey matter nuclei (p < 0.05). We confirmed the undersizing of total deep grey matter in FAS (vDTS = −6%) and identified a pattern of volumetric undersizing, most pronounced in the caudate (−13%) and globus pallidus (−11%), less so in the thalamus (−4%) and putamen (−2%) and sparing the accumbens (0%). These findings were consistent across segmentation tools, despite variations in magnitude. The pattern‐based classifier was more efficient than the one based on total deep grey matter alone (p < 0.001) and identified 32.4% of the NS‐FASD as having a FAS‐like deep grey matter phenotype, compared to 18.9% with the classifier based on total deep grey matter alone (p = 0.113). Added to a classifier based on TBV only, the pattern improved the performance (p = 0.033) of the model and increased identification of NS‐FASD with a FAS‐like neuroanatomical phenotype from 37.8% to 62.2% (p = 0.002). This study details the volumetric undersizing of deep grey matter in a large series of FASD patients. It reveals a differential pattern of vulnerability to prenatal alcohol exposure partially convergent across automatic segmentation tools. It also strongly suggests that this pattern of volumetric undersizing in the deep grey matter may contribute to a neuroanatomical signature of FAS that is usable to improve the probabilistic diagnosis of NS‐FASD by means of MRI‐based diagnostic classifiers.
- 19 May 2025
- Published by Wiley in Human Brain Mapping
- Vol. 46 (8) , e70233
Open AccessPattern of Deep Grey Matter Undersizing Boosts MRI‐Based Diagnostic Classifiers in Fetal Alcohol Spectrum Disorders
In fetal alcohol spectrum disorders (FASD), brain growth deficiency is a hallmark of subjects with both fetal alcohol syndrome (FAS) and nonsyndromic FASD (NS‐FASD, that is, those without specific diagnostic features). Although previous studies have suggested that the deep grey matter is heterogeneously affected at the group level, it has not yet been established within proper scaling modeling, nor has it been given a place in the FASD diagnostic criteria where neuroanatomical features still contribute almost nothing to diagnostic specificity. We segmented a 1.5T T1‐weighted brain MRI dataset of 90 monocentric FASD patients (53 FAS, 37 NS‐FASD) and 95 typically developing controls (ages 6–20), using volBrain‐vol2Brain as reference, and both Freesurfer‐SAMSEG and FSL‐FIRST to estimate result robustness. The segmentation resulted in seven anatomical volumes: total brain (TBV), total deep grey matter, caudate, putamen, globus pallidus, thalamus, and accumbens. After adjusting for confounds, we fitted the scaling relationship between deep grey matter nuclei volumes (Vi) and TBV (Vi = b × TBVa) and evaluated the effect of FAS on scaling. We then estimated the volumetric deviation from typical scaling (vDTS) for each deep grey nucleus volume in the FAS sample. Finally, we tested the improvement of FAS versus control classifiers based on total deep grey matter vDTS or total brain deviation from typical volume, by adding the five nuclear vDTS, both in terms of performance and generalizability to NS‐FASD. Scaling was significantly different between the FAS and control groups for all deep grey matter nuclei (p < 0.05). We confirmed the undersizing of total deep grey matter in FAS (vDTS = −6%) and identified a pattern of volumetric undersizing, most pronounced in the caudate (−13%) and globus pallidus (−11%), less so in the thalamus (−4%) and putamen (−2%) and sparing the accumbens (0%). These findings were consistent across segmentation tools, despite variations in magnitude. The pattern‐based classifier was more efficient than the one based on total deep grey matter alone (p < 0.001) and identified 32.4% of the NS‐FASD as having a FAS‐like deep grey matter phenotype, compared to 18.9% with the classifier based on total deep grey matter alone (p = 0.113). Added to a classifier based on TBV only, the pattern improved the performance (p = 0.033) of the model and increased identification of NS‐FASD with a FAS‐like neuroanatomical phenotype from 37.8% to 62.2% (p = 0.002). This study details the volumetric undersizing of deep grey matter in a large series of FASD patients. It reveals a differential pattern of vulnerability to prenatal alcohol exposure partially convergent across automatic segmentation tools. It also strongly suggests that this pattern of volumetric undersizing in the deep grey matter may contribute to a neuroanatomical signature of FAS that is usable to improve the probabilistic diagnosis of NS‐FASD by means of MRI‐based diagnostic classifiers.
- Open Access
- 11 February 2025
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 8 (4) , e202403065
A biallelic variant inGORASP1causes a novel Golgipathy with glycosylation and mitotic defects
GRASP65 is a Golgi-associated peripheral protein encoded by theGORASP1gene and required for Golgi cisternal stacking in vitro. A key role of GRASP65 in the regulation of cell division has also been suggested. However, depletion of GRASP65 in mice has little effect on the Golgi structure and the gene has not been associated with any human phenotype to date. Here, we report the identification of the first human pathogenic variant ofGORASP1(c.1170_1171del; p.Asp390Glufs*18) in a patient combining a neurodevelopmental disorder with neurosensory, neuromuscular, and skeletal abnormalities. Functional analysis revealed that the variant leads to a total absence of GRASP65. The structure of the Golgi apparatus did not show fragmentation, but glycosylation anomalies such as hyposialylation were detected. Mitosis analyses revealed an excess of prometaphases and metaphases with polar chromosomes, suggesting a delay in the cell cycle. These phenotypes were recapitulated in RPE cells in which a similar mutation was introduced by CRISPR/Cas9. These results indicate that loss of GRASP65 in humans causes a novel Golgipathy associated with defects in glycosylation and mitotic progression.
- 11 February 2025
- Published by Life Science Alliance, LLC in Life Science Alliance
- Vol. 8 (4) , e202403065
Open AccessA biallelic variant inGORASP1causes a novel Golgipathy with glycosylation and mitotic defects
GRASP65 is a Golgi-associated peripheral protein encoded by theGORASP1gene and required for Golgi cisternal stacking in vitro. A key role of GRASP65 in the regulation of cell division has also been suggested. However, depletion of GRASP65 in mice has little effect on the Golgi structure and the gene has not been associated with any human phenotype to date. Here, we report the identification of the first human pathogenic variant ofGORASP1(c.1170_1171del; p.Asp390Glufs*18) in a patient combining a neurodevelopmental disorder with neurosensory, neuromuscular, and skeletal abnormalities. Functional analysis revealed that the variant leads to a total absence of GRASP65. The structure of the Golgi apparatus did not show fragmentation, but glycosylation anomalies such as hyposialylation were detected. Mitosis analyses revealed an excess of prometaphases and metaphases with polar chromosomes, suggesting a delay in the cell cycle. These phenotypes were recapitulated in RPE cells in which a similar mutation was introduced by CRISPR/Cas9. These results indicate that loss of GRASP65 in humans causes a novel Golgipathy associated with defects in glycosylation and mitotic progression.
- Open Access
- 20 May 2023
- Published by Wiley in Human Brain Mapping
- Vol. 44 (11) , 4321-4336
Enhancing fetal alcohol spectrum disorders diagnosis with a classifier based on the intracerebellar gradient of volumetric undersizing
In fetal alcohol spectrum disorders (FASD), brain growth deficiency is a hallmark of subjects both with fetal alcohol syndrome (FAS) and with non‐syndromic FASD (NS‐FASD, i.e., those without specific diagnostic features). However, although the cerebellum was suggested to be more severely undersized than the rest of the brain, it has not yet been given a specific place in the FASD diagnostic criteria where neuroanatomical features still count for little if anything in diagnostic specificity. We applied a combination of cerebellar segmentation tools on a 1.5 T 3DT1 brain MRI dataset from a monocentric population of 89 FASD (52 FAS, 37 NS‐FASD) and 126 typically developing controls (6–20 years old), providing 8 volumes: cerebellum, vermis and 3 lobes (anterior, posterior, inferior), plus total brain volume. After adjustment of confounders, the allometric scaling relationship between these cerebellar volumes (Vi) and the total brain or cerebellum volume (Vt) was fitted (Vi = bVta), and the effect of group (FAS, control) on allometric scaling was evaluated. We then estimated for each cerebellar volume in the FAS population the deviation from the typical scaling (vDTS) learned in the controls. Lastly, we trained and tested two classifiers to discriminate FAS from controls, one based on the total cerebellum vDTS only, the other based on all the cerebellar vDTS, comparing their performance both in the FAS and the NS‐FASD group. Allometric scaling was significantly different between FAS and control group for all the cerebellar volumes (p < .001). We confirmed the excess of total cerebellum volume deficit (vDTS = −10.6%) and revealed an antero‐inferior‐posterior gradient of volumetric undersizing in the hemispheres (−12.4%, 1.1%, 2.0%, respectively) and the vermis (−16.7%, −9.2%, −8.6%, repectively). The classifier based on the intracerebellar gradient of vDTS performed more efficiently than the one based on total cerebellum vDTS only (AUC = 92% vs. 82%, p = .001). Setting a high probability threshold for >95% specificity of the classifiers, the gradient‐based classifier identified 35% of the NS‐FASD to have a FAS cerebellar phenotype, compared to 11% with the cerebellum‐only classifier (pFISHER = 0.027). In a large series of FASD, this study details the volumetric undersizing within the cerebellum at the lobar and vermian level using allometric scaling, revealing an anterior‐inferior‐posterior gradient of vulnerability to prenatal alcohol exposure. It also strongly suggests that this intracerebellar gradient of volumetric undersizing may be a reliable neuroanatomical signature of FAS that could be used to improve the specificity of the diagnosis of NS‐FASD.
- 20 May 2023
- Published by Wiley in Human Brain Mapping
- Vol. 44 (11) , 4321-4336
Open AccessEnhancing fetal alcohol spectrum disorders diagnosis with a classifier based on the intracerebellar gradient of volumetric undersizing
In fetal alcohol spectrum disorders (FASD), brain growth deficiency is a hallmark of subjects both with fetal alcohol syndrome (FAS) and with non‐syndromic FASD (NS‐FASD, i.e., those without specific diagnostic features). However, although the cerebellum was suggested to be more severely undersized than the rest of the brain, it has not yet been given a specific place in the FASD diagnostic criteria where neuroanatomical features still count for little if anything in diagnostic specificity. We applied a combination of cerebellar segmentation tools on a 1.5 T 3DT1 brain MRI dataset from a monocentric population of 89 FASD (52 FAS, 37 NS‐FASD) and 126 typically developing controls (6–20 years old), providing 8 volumes: cerebellum, vermis and 3 lobes (anterior, posterior, inferior), plus total brain volume. After adjustment of confounders, the allometric scaling relationship between these cerebellar volumes (Vi) and the total brain or cerebellum volume (Vt) was fitted (Vi = bVta), and the effect of group (FAS, control) on allometric scaling was evaluated. We then estimated for each cerebellar volume in the FAS population the deviation from the typical scaling (vDTS) learned in the controls. Lastly, we trained and tested two classifiers to discriminate FAS from controls, one based on the total cerebellum vDTS only, the other based on all the cerebellar vDTS, comparing their performance both in the FAS and the NS‐FASD group. Allometric scaling was significantly different between FAS and control group for all the cerebellar volumes (p < .001). We confirmed the excess of total cerebellum volume deficit (vDTS = −10.6%) and revealed an antero‐inferior‐posterior gradient of volumetric undersizing in the hemispheres (−12.4%, 1.1%, 2.0%, respectively) and the vermis (−16.7%, −9.2%, −8.6%, repectively). The classifier based on the intracerebellar gradient of vDTS performed more efficiently than the one based on total cerebellum vDTS only (AUC = 92% vs. 82%, p = .001). Setting a high probability threshold for >95% specificity of the classifiers, the gradient‐based classifier identified 35% of the NS‐FASD to have a FAS cerebellar phenotype, compared to 11% with the cerebellum‐only classifier (pFISHER = 0.027). In a large series of FASD, this study details the volumetric undersizing within the cerebellum at the lobar and vermian level using allometric scaling, revealing an anterior‐inferior‐posterior gradient of vulnerability to prenatal alcohol exposure. It also strongly suggests that this intracerebellar gradient of volumetric undersizing may be a reliable neuroanatomical signature of FAS that could be used to improve the specificity of the diagnosis of NS‐FASD.
- 8 July 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (9) , 1722-1726
Enlargement of the Optic Chiasm: A Novel Imaging Finding in Glutaric Aciduria Type 1
SUMMARY: Patients with glutaric aciduria type 1, without early diagnosis and initiation of preventive treatment, often develop movement disorders and various degrees of motor disability due to striatal area–specific damage induced by an acute episode of metabolic decompensation. The neuroimaging phenotype of patients with glutaric aciduria type 1 includes characteristic cyst-like bilateral enlargement of the Sylvian fissures and anterior subarachnoid spaces and signal abnormalities including supratentorial white matter and deep gray matter structure T2 hyperintensities, frequently associated with restricted diffusion. In this retrospective study, we add to the neuroimaging spectrum of glutaric aciduria type 1, a novel imaging finding present regardless of a previous metabolic crisis: the enlargement of the optic chiasm associated with signal abnormalities in the anterior intracranial visual structures observed in 6 of 10 patients. These optic pathway abnormalities are suggested as useful diagnostic clues for glutaric aciduria type 1, and possible pathophysiologic mechanisms are discussed.
- 8 July 2021
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 42 (9) , 1722-1726
Enlargement of the Optic Chiasm: A Novel Imaging Finding in Glutaric Aciduria Type 1
SUMMARY: Patients with glutaric aciduria type 1, without early diagnosis and initiation of preventive treatment, often develop movement disorders and various degrees of motor disability due to striatal area–specific damage induced by an acute episode of metabolic decompensation. The neuroimaging phenotype of patients with glutaric aciduria type 1 includes characteristic cyst-like bilateral enlargement of the Sylvian fissures and anterior subarachnoid spaces and signal abnormalities including supratentorial white matter and deep gray matter structure T2 hyperintensities, frequently associated with restricted diffusion. In this retrospective study, we add to the neuroimaging spectrum of glutaric aciduria type 1, a novel imaging finding present regardless of a previous metabolic crisis: the enlargement of the optic chiasm associated with signal abnormalities in the anterior intracranial visual structures observed in 6 of 10 patients. These optic pathway abnormalities are suggested as useful diagnostic clues for glutaric aciduria type 1, and possible pathophysiologic mechanisms are discussed.
- 27 June 2020
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 52 (5) , 1567-1568
Editorial for “Multiparametric MRI Radiomic Model for Preoperative Predicting WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma”
- 27 June 2020
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 52 (5) , 1567-1568
Editorial for “Multiparametric MRI Radiomic Model for Preoperative Predicting WHO/ISUP Nuclear Grade of Clear Cell Renal Cell Carcinoma”
- 1 June 2020
- Published by Elsevier in European Journal of Radiology
- Vol. 127, 108989
A preliminary study of the biochemical environment of infertile testes with clinical varicocele
- 1 June 2020
- Published by Elsevier in European Journal of Radiology
- Vol. 127, 108989
A preliminary study of the biochemical environment of infertile testes with clinical varicocele
- 30 March 2020
- Published by Springer Nature in European Radiology
- Vol. 30 (8) , 4284-4294
In vivo biochemical investigation of spermatogenic status: 1H-MR spectroscopy of testes with nonobstructive azoospermia
Objectives To evaluate the biochemical milieu in testes with nonobstructive azoospermia (NOA) by using proton MR spectroscopy (1H-MRS) in detecting differences in testicular metabolites between histological stages of NOA and in assessing the possible presence of spermatozoa before microdissection testicular sperm extraction (mTESE). Methods Forty-nine NOA men and fifty age-matched controls were included in this prospective study. A single-voxel point-resolved spectroscopy sequence with TR/TE (2000/25 ms) was used. NOA testes were classified using the higher Johnsen score (hJS) (group 1, hJS ≥ 8; and group 2, hJS < 8). Nonparametric statistical tests were used to assess differences in normalized metabolite concentrations, defined as ratios of the metabolite concentrations versus creatine concentration between (a) NOA and controls, (b) NOA groups, and (c) NOA with positive and negative sperm retrieval. Results Normalized concentrations of total choline (median 0.396 vs 1.09 mmol/kg, p = 0.002), myo-inositol (median 1.985 vs 3.19 mmol/kg, p = 0.002), and total lipids and macromolecules (TLM) resonating at 0.9 ppm (median 0.962 vs 2.43 mmol/kg, p = 0.024), 1.3 ppm (median 4.88 vs 10.7 mmol/kg, p = 0.043), and 2.0 ppm (median 2.33 vs 5.96 mmol/kg, p = 0.007) were reduced in NOA testes compared with controls. Decreased concentrations of TLM 2.0 (median 3.755 vs 0.436 mmol/kg, p = 0.043) were found in group 2 compared with group 1. Increased normalized concentrations of glutamate were observed in NOA testes with failed sperm retrieval (median 0.321 vs 0.000 mmol/kg, p = 0.028). Conclusions 1H-MRS provides metabolic information about the testis in NOA patients and assesses spermatogenic status before mTESE. Key Points • NOA testes differed from age-matched controls, in terms of reduced normalized concentrations of tChol, mI, and lipids. • TLM 2.0 peaks were found useful in the identification of NOA testes with the presence of foci of advanced spermatogenesis up to the haploid gamete stage. • Glu proved a reliable metabolic signature of spermatogenesis in NOA population by assessing the possible presence of sperm after mTESE.
- 30 March 2020
- Published by Springer Nature in European Radiology
- Vol. 30 (8) , 4284-4294
In vivo biochemical investigation of spermatogenic status: 1H-MR spectroscopy of testes with nonobstructive azoospermia
Objectives To evaluate the biochemical milieu in testes with nonobstructive azoospermia (NOA) by using proton MR spectroscopy (1H-MRS) in detecting differences in testicular metabolites between histological stages of NOA and in assessing the possible presence of spermatozoa before microdissection testicular sperm extraction (mTESE). Methods Forty-nine NOA men and fifty age-matched controls were included in this prospective study. A single-voxel point-resolved spectroscopy sequence with TR/TE (2000/25 ms) was used. NOA testes were classified using the higher Johnsen score (hJS) (group 1, hJS ≥ 8; and group 2, hJS < 8). Nonparametric statistical tests were used to assess differences in normalized metabolite concentrations, defined as ratios of the metabolite concentrations versus creatine concentration between (a) NOA and controls, (b) NOA groups, and (c) NOA with positive and negative sperm retrieval. Results Normalized concentrations of total choline (median 0.396 vs 1.09 mmol/kg, p = 0.002), myo-inositol (median 1.985 vs 3.19 mmol/kg, p = 0.002), and total lipids and macromolecules (TLM) resonating at 0.9 ppm (median 0.962 vs 2.43 mmol/kg, p = 0.024), 1.3 ppm (median 4.88 vs 10.7 mmol/kg, p = 0.043), and 2.0 ppm (median 2.33 vs 5.96 mmol/kg, p = 0.007) were reduced in NOA testes compared with controls. Decreased concentrations of TLM 2.0 (median 3.755 vs 0.436 mmol/kg, p = 0.043) were found in group 2 compared with group 1. Increased normalized concentrations of glutamate were observed in NOA testes with failed sperm retrieval (median 0.321 vs 0.000 mmol/kg, p = 0.028). Conclusions 1H-MRS provides metabolic information about the testis in NOA patients and assesses spermatogenic status before mTESE. Key Points • NOA testes differed from age-matched controls, in terms of reduced normalized concentrations of tChol, mI, and lipids. • TLM 2.0 peaks were found useful in the identification of NOA testes with the presence of foci of advanced spermatogenesis up to the haploid gamete stage. • Glu proved a reliable metabolic signature of spermatogenesis in NOA population by assessing the possible presence of sperm after mTESE.
- 1 October 2017
- Published by Elsevier in European Journal of Radiology
- Vol. 95, 265-270
Magnetic resonance diffusion tensor imaging of the testis: Preliminary observations
- 1 October 2017
- Published by Elsevier in European Journal of Radiology
- Vol. 95, 265-270
Magnetic resonance diffusion tensor imaging of the testis: Preliminary observations
- Open Access
- 31 March 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 71
Magnetic resonance imaging findings of cellular angiofibroma of the tunica vaginalis of the testis: a case report
Cellular angiofibroma represents a rare mesenchymal tumor typically involving the inguinoscrotal area in middle-aged men. Although the origin of this benign tumor is unknown, it is histologically classified as an angiomyxoid tumor. Cellular angiofibroma is characterized by a diversity of pathological and imaging features. An accurate preoperative diagnosis is challenging. Magnetic resonance imaging examination of the scrotum has been reported as a valuable adjunct modality in the investigation of scrotal pathology. The technique by providing both structural and functional information is useful in the differentiation between extratesticular and intratesticular diseases and in the preoperative characterization of the histologic nature of various scrotal lesions. There are few reports in the English literature addressing the magnetic resonance imaging findings of cellular angiofibroma of the scrotum and no reports on functional magnetic resonance imaging data. Here we present the first case of a cellular angiofibroma arising from the tunica vaginalis of the testis and we discuss the value of a multiparametric magnetic resonance protocol, including diffusion-weighted imaging, magnetization transfer imaging and dynamic contrast-enhanced magnetic resonance imaging in the preoperative diagnosis of this rare neoplasm. A 47-year Greek man presented with a painless left scrotal swelling, which had gradually enlarged during the last 6 months. Magnetic resonance imaging of his scrotum displayed a left paratesticular mass, in close proximity to the tunica vaginalis, with heterogeneous high signal intensity on T2-weighted images and no areas of restricted diffusion. The tumor was hypointense on magnetization transfer images, suggestive for the presence of macromolecules. On dynamic contrast-enhanced magnetic resonance imaging the mass showed intense heterogeneous enhancement with a type II curve. Magnetic resonance imaging findings were strongly suggestive of a benign paratesticular tumor, which was confirmed on pathology following lesion excision. Magnetic resonance imaging of the scrotum by combining conventional and functional magnetic resonance data provides useful diagnostic information in the preoperative characterization of scrotal masses. A possible diagnosis of a benign paratesticular tumor based on magnetic resonance imaging features may improve patient care and decrease the number of unnecessary radical surgical explorations.
- 31 March 2016
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 10 (1) , 71
Open AccessMagnetic resonance imaging findings of cellular angiofibroma of the tunica vaginalis of the testis: a case report
Cellular angiofibroma represents a rare mesenchymal tumor typically involving the inguinoscrotal area in middle-aged men. Although the origin of this benign tumor is unknown, it is histologically classified as an angiomyxoid tumor. Cellular angiofibroma is characterized by a diversity of pathological and imaging features. An accurate preoperative diagnosis is challenging. Magnetic resonance imaging examination of the scrotum has been reported as a valuable adjunct modality in the investigation of scrotal pathology. The technique by providing both structural and functional information is useful in the differentiation between extratesticular and intratesticular diseases and in the preoperative characterization of the histologic nature of various scrotal lesions. There are few reports in the English literature addressing the magnetic resonance imaging findings of cellular angiofibroma of the scrotum and no reports on functional magnetic resonance imaging data. Here we present the first case of a cellular angiofibroma arising from the tunica vaginalis of the testis and we discuss the value of a multiparametric magnetic resonance protocol, including diffusion-weighted imaging, magnetization transfer imaging and dynamic contrast-enhanced magnetic resonance imaging in the preoperative diagnosis of this rare neoplasm. A 47-year Greek man presented with a painless left scrotal swelling, which had gradually enlarged during the last 6 months. Magnetic resonance imaging of his scrotum displayed a left paratesticular mass, in close proximity to the tunica vaginalis, with heterogeneous high signal intensity on T2-weighted images and no areas of restricted diffusion. The tumor was hypointense on magnetization transfer images, suggestive for the presence of macromolecules. On dynamic contrast-enhanced magnetic resonance imaging the mass showed intense heterogeneous enhancement with a type II curve. Magnetic resonance imaging findings were strongly suggestive of a benign paratesticular tumor, which was confirmed on pathology following lesion excision. Magnetic resonance imaging of the scrotum by combining conventional and functional magnetic resonance data provides useful diagnostic information in the preoperative characterization of scrotal masses. A possible diagnosis of a benign paratesticular tumor based on magnetic resonance imaging features may improve patient care and decrease the number of unnecessary radical surgical explorations.